The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•22 April 2026•

1 min read

BIO-key Receives Nasdaq Non-Compliance Notice Over Delayed 10-K Filing

Key Facts

1BIO-key International received a Nasdaq notification for non-compliance with Listing Rule 5250(c)(1) due to its failure to timely file its Annual Report on Form 10-K.

BIO-key International, Inc. has received a formal notification from Nasdaq indicating that the company is no longer in compliance with Listing Rule 5250(c)(1). The deficiency stems from the company's failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. As a mandatory periodic filing for listed entities, the Form 10-K is crucial for maintaining regulatory transparency. While the notice serves as a standard procedural step, it does not trigger an immediate delisting of the company's common stock. BIO-key is now expected to submit a plan to regain compliance or file the delinquent report within a specified timeframe. This delay in financial reporting is generally viewed as a bearish signal, potentially impacting investor sentiment until the filing issues are resolved.

Sources: